printemailclick to share buttonfacebooktwitterlinkedin
2008 Research Chair Award Recipients
 

Cancer Imaging

Dr. Kristy Brock , Princess Margaret Hospital
Dr. David Kisselgoff *,Thunder Bay Regional Research Institute

Health Services Research (formerly Patterns of Care)

Dr. Christopher Booth , Queen’s University
Dr. David Hodgson , Princess Margaret Hospital
Dr. Hsien Seow *, McMaster University

Population Studies

Dr. Rayjean Hung , Mount Sinai Hospital
Dr. Scott Leatherdale , Cancer Care Ontario

* a recruitment license is an award that serves as a license to recruit a particular type of scientist into the Research Chair position

Applications were evaluated by the panel on the basis of scientific excellence and strategic alignment with the four research themes of Cancer Care Ontario’s scientist network program. The awards are for five years and are renewable for another three years.

Biographies

Dr. Christopher Booth

Dr. Booth studied medicine at Queen's University before undertaking further training in internal medicine and medical oncology at the University of Toronto. His clinical interests involve gastrointestinal and genitourinary cancer. He has an active research program in population-based cancer outcomes and clinical trial methodology. Specifically, he evaluates how the findings of landmark randomized controlled trials are translated into the general population and whether the societal benefits of therapy are what one might expect based on the clinical trial results.

He is currently completing a research fellowship at the National Cancer Institute of Canada Clinical Trials Group and will begin a full-time faculty appointment within the Division of Cancer Care and Epidemiology at the Queen's Cancer Research Institute in July 2008.

Dr. Kristy Brock

Dr. Kristy Brock received her PhD from the University of Michigan, Department of Nuclear Engineering and Radiological Sciences in 2003. Her thesis work was performed at the University of Michigan Department of Radiation Oncology and focused on the inclusion of deformation in dose accumulation in liver radiotherapy. Under the supervision of Dr. James Balter, her work represents some of the pioneering work of deformable registration in the radiotherapy context. She was one of the first people to successfully apply finite element models to describe shape changes in the liver due to breathing, which were further compared to geometric approximations. This work further indicated the potential improvements in the accuracy of calculations of the accumulated dose in the presence of physiological motion through the use of deformable registration.

Following the completion of her graduate work, she joined the staff at Princess Margaret Hospital (PMH), Radiation Medicine Program and became faculty in the Department of Radiation Oncology at the University of Toronto. At PMH she leads the investigation of deformable registration and modeling for treatment planning, delivery, and response assessment. This research has shown that deformable registration can improve the integration of multi-modality images for tumor definition, the accuracy of dose estimations in the presence of physiological motion, and targeting of tumors in image-guided radiotherapy. In addition, she has developed novel applications including validation of in-vivo imaging through correlation with histo-pathology and metrics for the assessment of tumor response. Collaborations with scientists in the Ontario Cancer Institute have expanded this research to investigate the applications of deformable registration for image guided therapeutics including surgery and photodynamic therapy.

Dr. Brock serves the academic community through membership on several committees including a task group on the use of image registration and data fusion in radiotherapy through the American Association of Physicists in Medicine. She also successfully conducted the first multi-institution, international deformable registration validation study using patient images in radiotherapy. Her contribution to the field has been recognized by numerous invited presentations at international meetings.

Dr. David Hodgson

David Hodgson, MD, MPH, is an Associate Professor and clinician scientist in the Department of Radiation Oncology and the Department of Health Policy, Management and Evaluation at the University of Toronto. He is a staff radiation oncologist at the Princess Margaret Hospital, and an Adjunct Scientist at the Institute for Clinical Evaluative Sciences in Toronto. He received his medical degree and radiation oncology training at the University of Toronto, and a Masters degree in Public Health from Harvard University.

He is a member of the Outcomes and Health Services Research Committee of the American Society for Therapeutic Radiology and Oncology, a member of the U.S. Children’s Oncology Group Hodgkin Lymphoma Steering Committee and Cardiovascular Toxicity Guidelines Task Force, and has participated in health technology assessment for the Ministry of Health and Long-Term Care of Ontario, Cancer Care Ontario’s Evidence-Based Guidelines initiative, and as the Chair of the Health Services Research Network for the Canadian Association of Radiation Oncologists.

His research activities include technology assessment and the utilization of population-based health administrative data to evaluate the treatment and outcome of cancer patients at the population level. He is currently the project co-lead on a study of health care utilization among cancer survivors conducted by Cancer Care Ontario’s Patterns of Care Research Network. He has been the recipient of a Career Development Award from the Ontario Ministry of Health and Long-Term Care and is the recipient of peer-reviewed funding from the Canadian Institutes for Health Research, the National Cancer Institute of Canada and Cancer Care Ontario.

Dr. Rayjean Hung

Dr. Rayjean Hung has more than four years of research experience in cancer epidemiology at the international level, and has extensive experience in the field of molecular and genetic epidemiology of various cancer sites, including cancers of lung, bladder, kidney, pancreas and childhood cancer. She holds a PhD in Epidemiology from UCLA, and completed a Postdoctoral Fellowship in Genetics and Epidemiology at the International Agency for Research on Cancer (IARC).

She is on the Graduate Faculty in the Department of Public Health Sciences, at the University of Toronto, and is a Principal Investigator at the Samuel Lunenfeld Research Institute in Toronto.

Throughout her research in IARC, WHO and UC Berkeley, she was responsible for study design, funding applications, statistical analyses including method development, as well as staff supervision and overall research planning and management.

In 2004, Dr. Hung established the International Lung Cancer Consortium in collaboration with IARC, the National Cancer Institute, MDACC and Harvard University, which connected more than 40 lung cancer research groups around the world. Dr. Hung has also been dedicated to genome-wide association studies in the past year, and has recently identified a lung cancer susceptibility gene in Ch15q25.

Dr. David Kisselgoff

Dr. David Kisselgoff is a Staff Radiologist at the Thunder Bay Regional Health Sciences Centre and Assistant Professor in Clinical Sciences Division at the Northern Ontario Medical School. He also holds the position of Clinical Scientist at Thunder Bay Regional Research Institute with the intention to participate in advanced cancer imaging and imaging guided interventions. He earned his medical degree in 1994 in Russia and completed his radiology residency in 2003 in Israel. Dr. Kisselgoff completed his clinical fellowship in musculoskeletal radiology at McMaster University between 2007 and 2008.

Since graduating, Dr. Kisselgoff has been working in cross-sectional imaging and general radiology with a special interest in musculoskeletal imaging and musculoskeletal ultrasound. He has also been conducting lectures for medical and nursing students and radiology technicians. His scientific research includes studies on MRI and digital mammography for breast cancer detection and clinical management and CT screening for lung cancer.

Dr. Scott Leatherdale

Dr. Scott Leatherdale is a Scientist in the Department of Population Studies & Surveillance at Cancer Care Ontario. He also has appointments as an Assistant Professor in the Dalla Lana School of Public Health at the University of Toronto, an Assistant Professor the Department of Health Studies and Gerontology at the University of Waterloo, and as an Associate Scientist with the Canadian Cancer Society / National Cancer Institute of Canada’s (CCS/NCIC) Centre for Behavioural Research and Program Evaluation (CBRPE).

Dr. Leatherdale is also a board member of the Institute Advisory Board for the Institute of Cancer Research (IAB-ICR) of the Canadian Institutes of Health Research (CIHR).

Dr. Leatherdale has received research grants to support his work in the areas of infrastructure development, population-level data collection systems, ecological influences on behaviour, research network development, knowledge exchange, lifestyle factors associated with cancer risk, program evaluation, and the impact of policy on cancer risk behaviours.

Dr. Leatherdale holds a PhD in Health Behaviour from the University of Waterloo and an MA in Human Development from Laurentian University. He is one of Canada's leading experts on understanding how environments influence behaviour and the development of data collection systems for population-based research. 

Dr. Hsien Seow

Dr. Hsien Seow is a health services researcher with interests in measuring and improving the quality of healthcare delivery for those with serious, chronic illness, such as cancer.  He is an Assistant Professor in the Department of Oncology at McMaster University, where he teaches health research and evaluation methods courses.  

He received his PhD from Johns Hopkins School of Public Health in 2009 from the Department of Health Policy and Management, concentrating in health services research and obtaining a certificate in gerontology.  Dr. Seow has worked with RAND Health in Washington DC, with the Center for Palliative Care Studies, where he led health policy research, quality improvement, and health advocacy initiatives.  He also holds a BSc in biology from Yale University in molecular, cellular, and developmental biology. 

Dr. Seow has previously worked as a research assistant in the fields of palliative care, electronic medical records, and end-of-life quality measures, and as a researcher/consultant with the Ministry of Health and Long-Term Care.

Last modified: Tue, Oct 25, 2011
cancer care ontario | action cancer ontario   620 University Avenue Toronto Ontario, Canada M5G 2L7   Phone: 416.971.9800 Fax: 416.971.6888

Please help improve the quality of our website by answering 10 brief questions in our online survey. Would you like to participate?

YesNo